Legend Biotech Income Statement (2019-2025) | LEGN

Income Statement Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 10.05M17.67M19.45M11.55M11.60M11.75M40.78M13.68M20.23M16.88M38.99M50.04M11.97M27.36M27.63M36.34M73.33M96.01M79.46M93.99M186.52M160.21M186.52M195.05M255.06M272.33M
Operating items
Research & Development -21.29M-41.92M-66.10M-48.00M-53.57M-63.66M-66.93M-0.07M-83.46M-72.31M-86.50M-81.55M-68.83M-104.52M-80.76M-84.89M-95.79M-95.86M-0.11M-100.96M-112.63M-95.52M-0.10M-101.92M-98.30M-113.15M
Selling, General & Administrative -1.10M-1.99M-2.05M-3.43M-4.51M-6.04M-9.17M-0.01M-9.25M-11.81M-17.14M-12.66M-18.05M-23.24M-26.68M-22.20M-27.75M-28.10M-0.03M-31.93M-35.35M-35.30M-0.03M-31.46M-32.59M-34.72M
Operating Expenses -22.39M-43.91M-68.14M-51.43M-58.08M-69.69M-76.11M-0.08M-92.71M-84.12M-103.64M-94.20M-86.88M-127.76M-107.44M-107.09M-123.54M-123.96M-0.13M-132.89M-147.98M-130.82M-0.14M-133.39M-130.90M-147.87M
Operating Income -70.36M-43.45M
EBIT -12.47M-27.87M-61.77M-51.93M-134.96M-67.14M-308.32M-0.09M-91.64M-124.96M-407.80M-33.17M-189.34M538.45M-140.58M106.86M193.65M-657.85M-0.15M65.26M-23.45M-70.36M40.51M-104.19M-130.02M-43.45M
Non-operating items
Interest & Investment Income -0.80M-2.93M-0.10M-0.13M-0.32M-0.97M-0.46M-1.33M-1.51M-8.18M-6.75M-12.01M-18.42M-13.87M17.05M16.63M-12.06M10.43M9.66M
Other Non Operating Income 1.25M-0.07M1.91M-1.21M2.02M4.87M1.49M8.11M-0.28M9.16M10.66M-3.64M-17.16M-49.06M12.19M-61.82M55.19M-109.99M-0.13M
Net income details
EBT -12.43M-27.79M-61.68M-47.94M-134.88M-67.05M-308.29M-0.09M-91.58M-124.75M-407.20M-32.13M-193.07M535.20M-135.72M111.97M198.84M-684.12M-0.15M59.79M-17.97M-120.89M40.51M-99.13M-124.80M-39.07M
Tax Provisions -0.01M-2.26M0.51M-0.07M0.00M-0.00M-3.61M-0.16M-0.16M-0.15M-0.15M-0.13M-0.29M0.29M0.00M-0.01M-0.23M-4.43M-0.01M-1.79M-0.58M-0.62M
Profit After Tax -12.43M-27.80M-63.94M-44.23M-134.88M-66.55M-57.83M-0.09M-91.58M-124.75M-88.33M-32.29M-193.23M-84.96M-135.88M-112.10M-199.13M-62.21M-0.14M-59.79M18.20M125.32M0.03M-100.92M125.38M39.69M
Income from Continuing Operations -12.43M-27.79M-59.42M-47.94M-134.88M-67.56M-308.21M-0.10M-91.58M-124.75M-403.58M-31.96M-192.91M535.35M-135.57M112.10M199.13M-684.40M-0.15M59.79M-17.74M-116.45M40.53M-97.34M-124.22M-38.46M
Consolidated Net Income -12.43M-27.79M-59.42M-47.94M-134.88M-67.56M-308.21M-0.10M-91.58M-124.75M-403.58M-31.96M-192.91M535.35M-135.57M112.10M199.13M-684.40M-0.15M59.79M-17.74M-116.45M40.53M-97.34M-124.22M-38.46M
Income towards Parent Company -12.43M-27.80M-63.94M-44.23M-134.88M-66.55M-57.83M-0.09M-91.58M-124.75M-88.33M-0.10730.10260.00-0.410.340.570.16-0.400.160.050.350.070.27-124.22M-38.46M
Net Income towards Common Stockholders -12.43M-27.80M-63.94M-44.23M-134.88M-66.55M-57.83M-0.09M-91.58M-124.75M-88.33M-0.10730.10260.00-0.410.340.570.16-0.400.160.050.350.070.27-124.22M-38.46M
Additional items
EPS (Basic) -0.25-0.17-0.52-0.26-0.220.00-0.33-0.45-0.300.000.000.000.000.000.000.000.000.000.000.000.000.00-0.34-0.10
EPS (Weighted Average and Diluted) -0.32-0.22-0.63-0.25-0.24-0.34-0.33-0.43-0.310.000.000.000.00-0.34
Shares Outstanding (Weighted Average) 258.70M258.70M258.70M258.70M258.70M266.29M277.02M277.02M290.66M308.46M308.70M308.70M308.70M330.13M330.50M362.71M363.58M363.82M364.57M364.61M366.90M367.30M368.06M369.14M
Shares Outstanding (Diluted Average) 200.00M200.00M215.55M264.33M236.31M0.27M277.02M289.92M281.70M308.70M318.08M365.20M366.56M368.27M
EBITDA -12.47M-27.87M-61.77M-51.93M-134.96M-67.14M-308.32M-76.55M-91.64M-124.96M-407.80M-38.78M-181.41M-89.14M-140.58M-98.59M-206.10M-82.45M-0.15M-107.79M28.73M63.42M40.51M60.73M1.18M40.57M
Interest Expenses -0.04M-0.08M-0.08M-3.99M-0.09M-0.09M-0.04M-38.00-0.05M-0.21M-0.60M-1.04M3.73M3.25M-4.86M-5.11M-5.18M26.27M-0.01M5.47M-5.48M-5.50M-0.01M-5.06M-5.22M-5.64M
Tax Rate 0.02%3.67%0.02%0.00%0.89%0.51%0.08%0.11%1.26%3.67%1.80%0.47%1.58%